178 related articles for article (PubMed ID: 20691337)
1. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines.
Kok SH; Chui CH; Lam WS; Chen J; Lau FY; Cheng GY; Wong RS; Lai PP; Leung TW; Tang JC; Chan AS
Int J Mol Med; 2006 May; 17(5):945-9. PubMed ID: 16596285
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
[TBL] [Abstract][Full Text] [Related]
8. Overview of Cantharidin and its Analogues.
Wang G; Dong J; Deng L
Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure evaluation of a novel cantharimide and its cytotoxicity on SK-Hep-1 hepatoma cells.
Kok SH; Chui CH; Lam WS; Chen J; Lau FY; Wong RS; Cheng GY; Lai PB; Leung TW; Yu MW; Tang JC; Chan AS
Bioorg Med Chem Lett; 2007 Mar; 17(5):1155-9. PubMed ID: 17240140
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
12. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis on carcinoma cells by two synthetic cantharidin analogues.
Kok SH; Chui CH; Lam WS; Chen J; Tang JC; Lau FY; Cheng GY; Wong RS; Chan AS
Int J Mol Med; 2006 Jan; 17(1):151-7. PubMed ID: 16328024
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
16. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
[TBL] [Abstract][Full Text] [Related]
17. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
18. Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma.
Feng IC; Hsieh MJ; Chen PN; Hsieh YH; Ho HY; Yang SF; Yeh CB
Environ Toxicol; 2018 Mar; 33(3):261-268. PubMed ID: 29159945
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.
To KK; Ho YP; Au-Yeung SC
Cancer Lett; 2005 Jun; 223(2):227-37. PubMed ID: 15896457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]